PDZ1 inhibitor peptide protects neurons against ischemia via inhibiting GluK2-PSD-95-module-mediated Fas signaling pathway

Brain Res. 2016 Apr 15:1637:64-70. doi: 10.1016/j.brainres.2016.02.019. Epub 2016 Feb 15.

Abstract

Respecting the selective inhibition of peptides on protein-protein interactions, they might become potent methods in ischemic stroke therapy. In this study, we investigated the effect of PDZ1 inhibitor peptide on ischemic neuron apoptosis and the relative mechanism. Results showed that PDZ1 inhibitor peptide, which significantly disrupted GluK2-PSD-95 interaction, efficiently protected neuron from ischemia/reperfusion-induced apoptosis. Further, PDZ1 inhibited FasL expression, DISC assembly and activation of Caspase 8, Bid, Caspase 9 and Caspase 3 after global brain ischemia. Based on our previous report that GluK2-PSD-95 pathway increased FasL expression after global brain ischemia, the neuron protection effect of PDZ1 inhibitor peptide was considered to be achieved by disrupting GluK2-PSD-95 interaction and subsequently inhibiting FasL expression and Fas apoptosis pathway.

Keywords: Cerebral ischemia; Fas; FasL; GluK2; PSD-95; Peptide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / metabolism
  • Brain Ischemia / pathology
  • Caspases / metabolism
  • Fas Ligand Protein / antagonists & inhibitors
  • Fas Ligand Protein / metabolism
  • Fas-Associated Death Domain Protein / metabolism
  • GluK2 Kainate Receptor
  • Guanylate Kinases / antagonists & inhibitors*
  • Guanylate Kinases / metabolism
  • Male
  • Membrane Proteins / antagonists & inhibitors
  • Membrane Proteins / metabolism
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology
  • Neuroprotective Agents / metabolism
  • PDZ Domains
  • Peptides / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Kainic Acid / antagonists & inhibitors*
  • Receptors, Kainic Acid / metabolism
  • Reperfusion Injury / metabolism
  • Signal Transduction

Substances

  • Fas Ligand Protein
  • Fas-Associated Death Domain Protein
  • Membrane Proteins
  • Neuroprotective Agents
  • Peptides
  • Receptors, Kainic Acid
  • Guanylate Kinases
  • Caspases